---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-004632"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:18:42.761113+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# United-Guardian Q2 2024 Sales Rise 28% to $3.39M, Net Income More Than Doubles to $956K

## Summary
- Net income for Q2 2024 was $956,225 ($0.21 per share) vs. $461,094 ($0.10 per share) in Q2 2023.
- Cosmetic ingredient sales surged 84% in Q2 and 115% for the first six months of 2024.
- Medical lubricant sales increased 15% in Q2 and 9% for the first half of 2024.
- Pharmaceutical sales rose 3% in Q2 but fell 13% for the six months due to Renacidin contract manufacturer shutdown; production resumed late March.
- Six-month sales reached $6.65 million and net income was $1.88 million, up from $5.22 million and $1.22 million a year earlier.

## SEC filing metadata
- accession: 0001171843-24-004632
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184324004632/0001171843-24-004632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184324004632/f8k_080824.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-004632
- JSON: https://secwatch.observer/filing/0001171843-24-004632.json
- Plain text: https://secwatch.observer/filing/0001171843-24-004632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.